Anti-inflammatory therapies for atherosclerosis
M Bäck, GK Hansson - Nature Reviews Cardiology, 2015 - nature.com
The view of atherosclerosis as an inflammatory disease has emerged from observations of
immune activation and inflammatory signalling in human atherosclerotic lesions, from the …
immune activation and inflammatory signalling in human atherosclerotic lesions, from the …
The interplay of lipids, lipoproteins, and immunity in atherosclerosis
Abstract Purpose of Review Atherosclerosis is an inflammatory disorder of the arterial wall,
in which several players contribute to the onset and progression of the disease. Besides the …
in which several players contribute to the onset and progression of the disease. Besides the …
Inflammation and the pathogenesis of atherosclerosis
P Libby - Vascular Pharmacology, 2024 - Elsevier
The notion that inflammation contributes to atherosclerosis has now gained considerable
currency. Inflammation participates in atherosclerosis inception, progression, and thrombotic …
currency. Inflammation participates in atherosclerosis inception, progression, and thrombotic …
Atherosclerosis as an inflammatory disease
A Tuttolomondo, D Di Raimondo… - Current …, 2012 - ingentaconnect.com
In many ways, atherosclerosis is a chronic inflammatory disorder and this issue is confirmed
by recent investigations of that have focused on inflammation, providing new insight into …
by recent investigations of that have focused on inflammation, providing new insight into …
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery
T Gui, A Shimokado, Y Sun, T Akasaka… - Mediators of …, 2012 - Wiley Online Library
Cardiovascular disease, a leading cause of mortality in developed countries, is mainly
caused by atherosclerosis, a chronic inflammatory disease. Macrophages, which …
caused by atherosclerosis, a chronic inflammatory disease. Macrophages, which …
Macrophages: promising targets for the treatment of atherosclerosis
HM Wilson, RN Barker, LP Erwig - Current vascular …, 2009 - ingentaconnect.com
Atherosclerosis is now recognised as a chronic inflammatory disease occurring within the
artery wall and ultimately responsible for myocardial infarction, stroke and peripheral …
artery wall and ultimately responsible for myocardial infarction, stroke and peripheral …
New insights and novel therapeutic potentials for macrophages in myocardial infarction
Z Zhang, J Tang, X Cui, B Qin, J Zhang, L Zhang… - Inflammation, 2021 - Springer
Cardiovascular disease (CVD) has long been the leading cause of death worldwide, and
myocardial infarction (MI) accounts for the greatest proportion of CVD. Recent research has …
myocardial infarction (MI) accounts for the greatest proportion of CVD. Recent research has …
Key chemokine pathways in atherosclerosis and their therapeutic potential
AB Márquez, EPC van der Vorst, SL Maas - Journal of Clinical Medicine, 2021 - mdpi.com
The search to improve therapies to prevent or treat cardiovascular diseases (CVDs) rages
on, as CVDs remain a leading cause of death worldwide. Here, the main cause of CVDs …
on, as CVDs remain a leading cause of death worldwide. Here, the main cause of CVDs …
Anti-inflammatory drugs and atherosclerosis
SP Moubayed, TM Heinonen… - Current opinion in …, 2007 - journals.lww.com
Due to the contributory inflammatory pathways in atherosclerosis, the properties of existing
and novel anti-inflammatory agents are being carefully and actively evaluated in …
and novel anti-inflammatory agents are being carefully and actively evaluated in …
Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications
E McNeill, KM Channon, DR Greaves - Clinical science, 2010 - portlandpress.com
Atherosclerosis is the pathological process that underlies the development of cardiovascular
disease, a leading cause of mortality. Atherosclerotic plaque formation is driven by the …
disease, a leading cause of mortality. Atherosclerotic plaque formation is driven by the …